APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Selected research

Industry Growth & Trends

Global Insulin Industry Growth and Trends Forecast to 2032

2 January 202696 pages

Choose your research edition.

Industry ResearchInsulin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Insulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Market by Company

Novo Nordisk

Eli Lilly

Sanofi-Aventis

Tonghua Dongbao

Ganlee

United Laboratory

Jiangsu Wanbang

Insulin Segment by Type

Animal Insulin

Regular Human Insulin

Insulin Analogue

Insulin Segment by Application

Short Acting

Intermediate Acting

Long Acting

Pre-Mix Insulin

Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Animal Insulin Table 2. Major Company of Regular Human Insulin Table 3. Major Company of Insulin Analogue Table 4. Global Insulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Insulin Sales by Type (2021-2026) & (M Pcs) Table 6. Global Insulin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Insulin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Insulin Sales Market Share in Value by Type (2021-2026) Table 9. Global Insulin Price by Type (2021-2026) & (US$/Pcs) Table 10. Global Insulin Sales by Type (2027-2032) & (M Pcs) Table 11. Global Insulin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Insulin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Insulin Sales Market Share in Value by Type (2027-2032) Table 14. Global Insulin Price by Type (2027-2032) & (US$/Pcs) Table 15. North America Insulin Sales by Type (2021-2026) & (M Pcs) Table 16. North America Insulin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Insulin Sales by Type (2021-2026) & (M Pcs) Table 18. Europe Insulin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Insulin Sales by Type (2021-2026) & (M Pcs) Table 20. Asia-Pacific Insulin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Insulin Sales by Type (2021-2026) & (M Pcs) Table 22. Latin America Insulin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Insulin Sales by Type (2021-2026) & (M Pcs) Table 24. Middle East and Africa Insulin Sales by Type (2021-2026) & (US$ Million) Table 25. Insulin Industry Trends Table 26. Insulin Industry Drivers Table 27. Insulin Industry Opportunities and Challenges Table 28. Insulin Industry Restraints Table 29. Global Insulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Insulin Revenue Market Share by Company (2021-2026) Table 31. Global Insulin Sales by Company (2021-2026) & (M Pcs) Table 32. Global Insulin Sales Share by Company (2021-2026) Table 33. Global Insulin Market Price by Company (2021-2026) & (US$/Pcs) Table 34. Global Insulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Insulin Major Company Production Sites and Headquarters Table 36. Global Insulin Company, Product Type & Application Table 37. Global Insulin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Insulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Insulin Sales by Region (2021-2026) & (M Pcs) Table 42. Global Insulin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Insulin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Insulin Sales Market Share in Value by Region (2021-2026) Table 45. Global Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 46. Global Insulin Sales by Region (2027-2032) & (M Pcs) Table 47. Global Insulin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Insulin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Insulin Sales Market Share in Value by Region (2027-2032) Table 50. Global Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 51. Global Insulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Insulin Sales by Application (2021-2026) & (M Pcs) Table 53. Global Insulin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Insulin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Insulin Sales Market Share in Value by Application (2021-2026) Table 56. Global Insulin Price by Application (2021-2026) & (US$/Pcs) Table 57. Global Insulin Sales by Application (2027-2032) & (M Pcs) Table 58. Global Insulin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Insulin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Insulin Sales Market Share in Value by Application (2027-2032) Table 61. Global Insulin Price by Application (2027-2032) & (US$/Pcs) Table 62. North America Insulin Sales by Application (2021-2026) & (M Pcs) Table 63. North America Insulin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Insulin Sales by Application (2021-2026) & (M Pcs) Table 65. Europe Insulin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Insulin Sales by Application (2021-2026) & (M Pcs) Table 67. Asia-Pacific Insulin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Insulin Sales by Application (2021-2026) & (M Pcs) Table 69. Latin America Insulin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Insulin Sales by Application (2021-2026) & (M Pcs) Table 71. Middle East and Africa Insulin Sales by Application (2021-2026) & (US$ Million) Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 75. Novo Nordisk Insulin Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Eli Lilly Company Information Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 80. Eli Lilly Insulin Product Portfolio Table 81. Eli Lilly Recent Development Table 82. Sanofi-Aventis Company Information Table 83. Sanofi-Aventis Business Overview Table 84. Sanofi-Aventis Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 85. Sanofi-Aventis Insulin Product Portfolio Table 86. Sanofi-Aventis Recent Development Table 87. Tonghua Dongbao Company Information Table 88. Tonghua Dongbao Business Overview Table 89. Tonghua Dongbao Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 90. Tonghua Dongbao Insulin Product Portfolio Table 91. Tonghua Dongbao Recent Development Table 92. Ganlee Company Information Table 93. Ganlee Business Overview Table 94. Ganlee Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 95. Ganlee Insulin Product Portfolio Table 96. Ganlee Recent Development Table 97. United Laboratory Company Information Table 98. United Laboratory Business Overview Table 99. United Laboratory Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 100. United Laboratory Insulin Product Portfolio Table 101. United Laboratory Recent Development Table 102. Jiangsu Wanbang Company Information Table 103. Jiangsu Wanbang Business Overview Table 104. Jiangsu Wanbang Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 105. Jiangsu Wanbang Insulin Product Portfolio Table 106. Jiangsu Wanbang Recent Development Table 107. North America Insulin Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 108. North America Insulin Sales by Country (2021-2026) & (M Pcs) Table 109. North America Insulin Sales Market Share by Country (2021-2026) Table 110. North America Insulin Sales Forecast by Country (2027-2032) & (M Pcs) Table 111. North America Insulin Sales Market Share Forecast by Country (2027-2032) Table 112. North America Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Insulin Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Insulin Market Share by Country (2021-2026) Table 115. North America Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Insulin Market Share Forecast by Country (2027-2032) Table 117. Europe Insulin Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 118. Europe Insulin Sales by Country (2021-2026) & (M Pcs) Table 119. Europe Insulin Sales Market Share by Country (2021-2026) Table 120. Europe Insulin Sales Forecast by Country (2027-2032) & (M Pcs) Table 121. Europe Insulin Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Insulin Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Insulin Market Share by Country (2021-2026) Table 125. Europe Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Insulin Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Insulin Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Insulin Sales by Country (2021-2026) & (M Pcs) Table 129. Asia-Pacific Insulin Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Insulin Sales Forecast by Country (2027-2032) & (M Pcs) Table 131. Asia-Pacific Insulin Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Insulin Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Insulin Market Share by Country (2021-2026) Table 135. Asia-Pacific Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Insulin Market Share Forecast by Country (2027-2032) Table 137. Latin America Insulin Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 138. Latin America Insulin Sales by Country (2021-2026) & (M Pcs) Table 139. Latin America Insulin Sales Market Share by Country (2021-2026) Table 140. Latin America Insulin Sales Forecast by Country (2027-2032) & (M Pcs) Table 141. Latin America Insulin Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Insulin Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Insulin Market Share by Country (2021-2026) Table 145. Latin America Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Insulin Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Insulin Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Insulin Sales by Country (2021-2026) & (M Pcs) Table 149. Middle East and Africa Insulin Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Insulin Sales Forecast by Country (2027-2032) & (M Pcs) Table 151. Middle East and Africa Insulin Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Insulin Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Insulin Market Share by Country (2021-2026) Table 155. Middle East and Africa Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Insulin Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Insulin Distributors List Table 160. Insulin Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Insulin Image Figure 2. Global Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Sales (2021-2032) & (M Pcs) Figure 5. Animal Insulin Image Figure 6. Global Animal Insulin Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. Regular Human Insulin Image Figure 8. Global Regular Human Insulin Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Insulin Analogue Image Figure 10. Global Insulin Analogue Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Global Insulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Insulin Market Share by Type 2025 VS 2032 Figure 13. North America Insulin Sales Market Share in Volume by Type in 2025 Figure 14. North America Insulin Sales Market Share in Value by Type in 2025 Figure 15. Europe Insulin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Insulin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Insulin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Insulin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Insulin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Insulin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Insulin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Insulin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Insulin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Short Acting Image Figure 26. Global Short Acting Sales YoY Growth (2021-2032) & (M Pcs) Figure 27. Intermediate Acting Image Figure 28. Global Intermediate Acting Sales YoY Growth (2021-2032) & (M Pcs) Figure 29. Long Acting Image Figure 30. Global Long Acting Sales YoY Growth (2021-2032) & (M Pcs) Figure 31. Pre-Mix Insulin Image Figure 32. Global Pre-Mix Insulin Sales YoY Growth (2021-2032) & (M Pcs) Figure 33. Global Insulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Insulin Market Share by Application 2025 VS 2032 Figure 35. North America Insulin Sales Market Share in Volume by Application in 2025 Figure 36. North America Insulin Sales Market Share in Value by Application in 2025 Figure 37. Europe Insulin Sales Market Share in Volume by Application in 2025 Figure 38. Europe Insulin Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Insulin Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Insulin Sales Market Share in Value by Application in 2025 Figure 41. Latin America Insulin Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Insulin Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Insulin Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Insulin Sales Market Share in Value by Application in 2025 Figure 45. North America Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 46. North America Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 50. Europe Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 54. Asia-Pacific Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 58. Latin America Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 62. Middle East and Africa Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Insulin Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Insulin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Animal Insulin
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Sanofi-Aventis
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Jiangsu Wanbang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Market by Type
  6. 1.3.1 Animal Insulin
  7. 1.3.2 Regular Human Insulin
  8. 1.3.3 Insulin Analogue
  9. 1.4 Global Insulin Market Size by Type
  10. 1.4.1 Global Insulin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Insulin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Insulin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Insulin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Insulin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Insulin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Insulin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Insulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Industry Trends
  2. 2.2 Insulin Industry Drivers
  3. 2.3 Insulin Industry Opportunities and Challenges
  4. 2.4 Insulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Price (2021-2026)
  4. 3.4 Global Insulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Company, Product Type & Application
  7. 3.7 Global Insulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Tier 1, Tier 2, and Tier 3
4 Insulin Regional Status and Outlook
  1. 4.1 Global Insulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Historic Market Size by Region
  3. 4.2.1 Global Insulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin by Application
  1. 5.1 Insulin Market by Application
  2. 5.1.1 Short Acting
  3. 5.1.2 Intermediate Acting
  4. 5.1.3 Long Acting
  5. 5.1.4 Pre-Mix Insulin
  6. 5.2 Global Insulin Market Size by Application
  7. 5.2.1 Global Insulin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Insulin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Insulin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Insulin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Insulin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Insulin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Insulin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Insulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk
  2. 6.1.1 Novo Nordisk Company Information
  3. 6.1.2 Novo Nordisk Business Overview
  4. 6.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk Insulin Product Portfolio
  6. 6.1.5 Novo Nordisk Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Insulin Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Sanofi-Aventis
  14. 6.3.1 Sanofi-Aventis Company Information
  15. 6.3.2 Sanofi-Aventis Business Overview
  16. 6.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi-Aventis Insulin Product Portfolio
  18. 6.3.5 Sanofi-Aventis Recent Developments
  19. 6.4 Tonghua Dongbao
  20. 6.4.1 Tonghua Dongbao Company Information
  21. 6.4.2 Tonghua Dongbao Business Overview
  22. 6.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tonghua Dongbao Insulin Product Portfolio
  24. 6.4.5 Tonghua Dongbao Recent Developments
  25. 6.5 Ganlee
  26. 6.5.1 Ganlee Company Information
  27. 6.5.2 Ganlee Business Overview
  28. 6.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ganlee Insulin Product Portfolio
  30. 6.5.5 Ganlee Recent Developments
  31. 6.6 United Laboratory
  32. 6.6.1 United Laboratory Company Information
  33. 6.6.2 United Laboratory Business Overview
  34. 6.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 United Laboratory Insulin Product Portfolio
  36. 6.6.5 United Laboratory Recent Developments
  37. 6.7 Jiangsu Wanbang
  38. 6.7.1 Jiangsu Wanbang Company Information
  39. 6.7.2 Jiangsu Wanbang Business Overview
  40. 6.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Wanbang Insulin Product Portfolio
  42. 6.7.5 Jiangsu Wanbang Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Sales by Country
  2. 7.1.1 North America Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Market Size by Country
  6. 7.2.1 North America Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Sales by Country
  2. 8.1.1 Europe Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Market Size by Country
  6. 8.2.1 Europe Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Sales by Country
  2. 10.1.1 South America Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Market Size by Country
  6. 10.2.1 South America Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Value Chain Analysis
  2. 12.1.1 Insulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Production Mode & Process
  7. 12.2 Insulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Distributors
  10. 12.2.3 Insulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst